Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Price: $0.55 | Change: +$0.005 | %Change: +0.92%
Volume: 37,396 | Day High/Low: 0.55/0.54 | 52 Week High/Low: 0.65/0.19

View modes: 
5 stars

RE:RE:RE:RE:RE:Looks like an announcement will be made soon on resumption

ALL long term shareholders are extremely frustrated by TH ALWAYS ALWAYS under delivering  rate and reply
5 stars

RE:RE:RE:RE:Looks like an announcement will be made soon on resumption

At this point we are almost half way through the Aug 15 to Sept 15 period.  I am a little skeptical that anything will actually be announced in this time period.  The way I have seen management...read more
0 stars

RE:RE:RE:Looks like an announcement will be made soon on resumption

I guess that I was wrong ......no announcement yet Are the buyers just relying on the statement made during the last CC that product will be available sometime between August 15 and Sept 15 ? I think...read more
0 stars

RE:RE:Looks like an announcement will be made soon on resumption

surprising that the stock is not halted ......  rate and reply
0 stars

RE:Looks like an announcement will be made soon on resumption

very active today ..huge spike in volume.................on no news??  rate and reply
0 stars

Looks like an announcement will be made soon on resumption

of shipment.....late day buying interest on TH  rate and reply
4 stars

study details published----

not sure if this is new http://www.medpagetoday.com/MeetingCoverage/IAC/46848  rate and reply
3.5 stars

More manufacturing issues

Loss of  inventory in June due to manufacturing issues!!! seems they have completely lost control of manufacturing Running out of cash soon if they cant resolve these issues zeto revenues and sky high...read more
0 stars

Bunch of clowns

Fall is now summer and  2 mg distribution is now nil Just 72 hrs after the Pr  rate and reply
0 stars

RE:RE:RE:RE:1mg dose not available until Fall 2014

Apparantly "Required documentation for the 1mg/vial presentation has been filed with the FDA". Seems there are some hoops to jump through that management hadn't thought about. It looks to me that...read more
0 stars

RE:RE:RE:1mg dose not available until Fall 2014

Where did you read that production problems were behind ?why wont they make the 1 mg vial available until fall?  rate and reply
0 stars

RE:RE:1mg dose not available until Fall 2014

It is actually very, very good news. The production problems are now behind the company. It will sell 2mg vials from its inventory for the next few months and they are more profitable than the 1mg...read more
0 stars

RE:1mg dose not available until Fall 2014

I am so sick and tired of half truths and deceptive behaviour it will take almost one year to be able to make the 1 mg vial again and absolutely no explanation for the delay  rate and reply
0 stars

1mg dose not available until Fall 2014

Bad news!!! Did Tanguay lie in the last CC?  rate and reply
0 stars

RE:price action today

Finished at HOD. And UBS was not even contributing. Production was supposed to start back up before the end of Q2. That is the end of this month.  rate and reply
0 stars

price action today

would indicate that more good news on the way...I hope that they have finally resumed production  rate and reply
0 stars

Thera regains all rights to Egriffa in both US&Canada market

"Theratechnologies Regains Rights to EGRIFTA(R) (tesamorelin for injection) in the United States Closing of Transaction Marks New Era for Theratechnologies MONTREAL, QUEBEC--(Marketwired - May 1...read more
0 stars

RE:RE:RE:RE:Health Canada approval, finally

At this current PPS, Thera entire market cap is just $33 million. So, annual revenue of $30 million which is equal to Serrono annual sale of Egriffa in US alone would be about equal to market cap...read more
0 stars

RE:RE:RE:Health Canada approval, finally

They don't have to better than serono. If the sell the same, $30 million/year then I should be able to get more than 63 cents a share. That would be revenue of 50 cents/share.  rate and reply
0 stars

RE:RE:RE:Health Canada approval, finally

I believe Thera could do better than Serrono as the latter has been dragging its feet for some unknown motives....Serrono/Merck probably could not tolerate the fact that a small guy could have beaten...read more